-
Ma Qiulin, Vice Governor of Jiangsu Provincial People's Government, investigates food and drug supervision work
Time of Update: 2022-09-16
At present and in the future, we must conscientiously study and implement the spirit of the 19th National Congress of the Communist Party of China, insist on arming our minds and guiding practice with Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, and comprehensively improve the modernization level of food and drug safety management .
-
Life and death speed
Time of Update: 2022-08-15
，、，。~5200（~1000）、，，、、、、、、，，，。，、， 20161123，【】solanezumab， 2018214，！APECS。Verubecestat（MK-8931） 2019130，！ 2019322，！(Biogen)。！ On May 10th, local time in the United States, Endpoints News, a well-known
-
Coron is on the hook
Time of Update: 2022-04-16
Highlights Recently, Kelun Pharmaceutical has made new progress in research and development: the marketing application of troglitatin succinate tablets has entered the approval process, and the omega
-
A large number of pharmacies have been rectified, and these problems should be paid attention
Time of Update: 2022-03-05
Among them, it is worth noting that in January, a total of 6 pharmacies in Bozhou failed to pass the inspection due to the problem of "(licensed) pharmacists not on duty", and 1 pharmacy was even put on file for investigation, and the remaining 5 were investigated according to the severity of the circumstances.
-
New progress of central nervous system infectious diseases in 2021, one article inventory
Time of Update: 2022-02-21
(3) Professor Fuhua Peng introduced that cryptococcal infection-related encephalitis syndrome has encountered more than 60 cases of non-HIV cryptococcal meningitis patients in his hospital, usually 2-3 times the lumbar puncture review was negative for Cryptococcus, and suddenly new cases appeared.
-
Target PD-1 and LAG-3
Time of Update: 2021-09-20
Text|Pharmaceutical Mission HillsThe Center for Drug Evaluation (CDE) of the National Medical Products Administration of China revealed that Roche's application for a new class 1 drug RO7247669 injection has obtained an implied license for a clinical trial and is intended to be developed for the treatment of liver cancer .
-
Hengrui 1.3 billion "shopping
Time of Update: 2021-09-12
The cooperation with Dalian Wanchun is also regarded by the outside world as Hengrui Pharmaceuticals is leveraging local emerging pharmaceutical companies to break through innovative research and development, and it is also Sun Piaoyang's plan to implement his good medicine .
-
Zejing Biotech's Class 1 innovative drug Donafinil Toluenesulfonate Tablets Approved
Time of Update: 2021-06-30
Recently, the National Medical Products Administration approved the first class innovative drug Donafinil Tosylate (trade name: Zeprosyn) declared by Suzhou Zejing Biopharmaceutical Co.
It is used for patients with unresectable hepatocellular carcinoma who have not received systemic treatment in the past .
-
Another new star in the field of hypoglycemia-Simeglutide "Indications for Weight Loss" was officially approved
Time of Update: 2021-06-18
This is the first drug approved by the FDA for weight management in chronic obese or overweight adults since 2014 .
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014[EB/OL].
-
Successfully promote hair regrowth
Time of Update: 2021-05-02
Today, Eli Lilly and Incyte announced that their JAK inhibitor baricitinib has achieved positive results in the second phase 3 clinical trial BRAVE-AA1 for the treatment of patients with severe alopecia areata.
-
Amgen received nearly US$2 billion in innovative first-line treatments for gastric cancer, Zai Lab owns rights in Greater China
Time of Update: 2021-03-23
In January this year, the US FDA accelerated the approval of the HER2 targeting antibody conjugate drug Enhertu jointly developed by AstraZeneca and Daiichi Sankyo to expand the scope of application to treat HER2-positive locally advanced or metastatic gastric cancer.
-
CFDA Launches New Drug Production License
Time of Update: 2021-02-03
Notice of the General Administration of Food and Drug Administration on the Re-issue of the Drug Production License and the Medical Institution Preparation License The State Administration of Food and
-
Scientists have revealed for the first time the anti-tumor immune function of cell coke death
Time of Update: 2020-12-30
The research shows the advantages of high efficiency and good bio orthopaedicity of the "dual-target activation" strategy based on boron tifluoride desilicon reaction, and on the other hand, it reveals the great potential of the idea of transforming the probe into an activator in activating living proteins.
-
Methods for the Pasteurella Glycosaminoglycan Synthases: Enzymes that Polymerize Hyaluronan, Chondroitin, or Heparosan Chains
Time of Update: 2020-12-23
Multiple glycosyltransferases (GTases) that produce glycosaminoglycans (GAGs) have been identified; �several distinct putative architectures and catalytic abilities have been noted from microbes and vertebrates.
The related Chapter 18 is focused on larger molecular weight GAGs analyses as well as the Class I membrane streptococcal and mammalian HA synthases.
-
NMPA Release: Drug Commissioned Production Quality Agreement Guide, Template
Time of Update: 2020-10-24
Guidelines for Drug Commissioned Production Quality Agreement (2020 edition) 2.
Drug Commissioned Production Quality Agreement Template (2020 edition) State Drug Administration September 27, 2020.
